- Since 2018, export NOC and manufacturing license were granted by State Licensing Authority for manufacturing unapproved/banned/new drugs solely for export purposes.
- However, in recent notification sole licensing authority will be Central Drugs Standard Control Organisation (CDSCO).
- All manufacturers are required to obtain NOC from respective Zonal offices of CDSCO through SUGAM Portal.
- The decision comes in view of Drug Consultative Committee's observation that process of obtaining NOCs from state drug regulators for pharmaceutical products is time-consuming, further delaying export consignment.
- About Indian Pharmaceutical Industry (PI)
- Widely recognised as ‘Pharmacy of the World’
- Largest provider of generic medicines globally, occupying a 20% share in global supply by volume.
- Contributes 70% of Diphtheria, Tetanus and Pertussis (DPT) and Bacillus Calmette–Guérin (BCG) vaccines, and 90% of measles vaccines.
- It is expected to reach USD 130 Billion by 2030.
- Challenges in Indian Pharmaceutical Industry
- Dependence on China for Active Pharmaceutical Ingredients.
- Instances of contaminated drugs and cough syrups manufactured in India.
- Low investments in Research & Development.
- Initiatives taken to strengthen Pharma Industry
- Production Linked Incentive (PLI) scheme for Pharmaceuticals.
- Strengthening of Pharmaceutical Industry Scheme.
- Scheme for Promotion of Bulk Drug Parks.
About CDSCO
|